Nephrocare Health Services has debuted at Rs 491.70 on the BSE, up by 31.7 points or 6.89% from its issue price of Rs 460.00.
The scrip is currently trading at Rs. 478.00, up by 18 points or 3.91% from its issue price.
It has touched a high and low of Rs. 498.70 and Rs. 475.95 respectively. So far 14.00 lakh shares were traded on the counter.
The offering, which was open for subscription between December 10, 2025 and December 12, 2025 was subscribed 14.08 times. The issue price was fixed at Rs 460.00 per share i.e. at upper end of price band of Rs 438-460 apiece.
Nephrocare Health Services offers comprehensive dialysis care through its network of clinics - from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported by pharmacy.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7555.95 |
| Max Healthcare Inst | 990.85 |
| Narayana Hrudayalay | 1773.75 |
| Aster DM Healthcare | 675.15 |
| Global Health | 1094.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: